Device / Technology News

RSS

New tool to detect inflammatory eye disease at molecular level before damage occurs

Forget what you know about how diseases are diagnosed-new research published in the May 2010 print issue of The FASEB Journal details a noninvasive ground-breaking tool that detects signs of disease at early molecular stages before symptoms can be seen using traditional methods.

30 Apr 2010

CT Dose Summit to establish freely available guidelines for performing CT scans

A national "CT Dose Summit" in Atlanta, GA this week will bring together some of the world's leading experts on medical imaging to lay the foundation for assembling optimized guidelines for performing CT scans -- a common medical imaging procedure that uses X-rays to show cross-sectional images of the body.

30 Apr 2010

States move to require ultrasounds before abortions

Various states have passed or are considering bills to tighten abortion regulations.

30 Apr 2010

Generex Biotechnology receives U.S. patent for method of administering insulin to the buccal region

Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has received a new patent in the United States.

30 Apr 2010

CSI announces completion of enrollment in CALCIUM 360° clinical trial for PAD

Cardiovascular Systems, Inc. (CSI), has completed patient enrollment in its prospective, randomized CALCIUM 360° clinical trial, part of the company's 360° Clinical Series. The CALCIUM 360° feasibility study is evaluating the treatment of peripheral arterial disease (PAD) behind and below the knee using CSI's Diamondback 360® System, a minimally invasive catheter for treating PAD anywhere in the leg. Dr. Nicolas Shammas, an interventional cardiologist at Trinity Medical Center, Bettendorf, Iowa, is the study's principal investigator.

30 Apr 2010

EndoChoice granted FDA marketing clearance for BONASTENT Esophageal and Biliary Stent platforms

EndoChoice, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its BONASTENT® Fully Covered Esophageal Stent for the treatment of malignant esophageal obstructions, and its BONASTENT Uncovered Biliary Stent for the treatment of malignant biliary obstructions.

30 Apr 2010

A crystal ball into your future health!

Imagine knowing just what diseases you are likely to suffer from in your lifetime thanks to the sequencing of your genes. That is exactly what Professor Stephen Quake knows, because he has had his entire genome sequenced and studied. In fact he was in the news last year as well when he used new technology to sequence his genetic code for less than $50,000.

29 Apr 2010

ZOLL Medical's second-quarter revenues up 15% to $107.1 million

ZOLL Medical Corporation, a manufacturer of resuscitation devices and software solutions, today announced that revenues for the second quarter of fiscal 2010 increased 15% to $107.1 million, compared to revenues in the second quarter of last year of $92.7 million. Revenue results included a positive foreign exchange impact of approximately $2.2 million, compared to the second quarter of fiscal 2009.

29 Apr 2010

IMD seeks FDA regulatory clearance for NADiA ProsVue prostate cancer prognostic test

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, announced today that its IRIS Molecular Diagnostics (IMD) subsidiary has submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory clearance for NADiA®ProsVue™, a prostate cancer prognostic test. The test is designed to help physicians identify patients at low risk of cancer recurrence post radical prostatectomy.

29 Apr 2010

NeoGenomics first-quarter revenue up 22%

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the first quarter 2010.

29 Apr 2010

Orion Health Rhapsody Integration Engine to be deployed across Philips' healthcare informatics solutions

Royal Philips Electronics today announced an agreement with Orion Health™, a leading provider of integration solutions in healthcare, to deploy the Orion Health Rhapsody® Integration Engine across Philips' portfolio of healthcare informatics solutions.

From Philips Healthcare 29 Apr 2010

China Medical Technologies' AUTOMAGLIA 90 analyzer and Down Syndrome Screening receive SFDA approval

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that it received approval for its AUTOMAGLIA 90 fully-automated ECLIA analyzer as well as Down Syndrome screening kit from the State Food and Drug Administration of China.

29 Apr 2010

Artificial heart to be a reality soon, expect researchers

There is good news for heart patients waiting in line for a heart transplant. A team of researchers in Queensland, Malaysia, Germany and Japan are working on an artificial heart. They plan to try it first in sheep.

29 Apr 2010

New FineThanx phone system gives peace of mind to elderly patients

In a new system, telephone calls twice a day find out how an aging loved one is doing. Then the system reports back the good news or bad.

29 Apr 2010

Tomophase receives seventh U.S. Patent for OCTIS component

Tomophase Corporation, a leading developer of non-invasive optical coherence tomography (OCT) tissue imaging devices, announced today that it has received notification of the issuance of its seventh patent: Delivering Light via Optical Waveguide and Multi-view Optical Probe Head, U. S. Patent # 7,706,646.

29 Apr 2010

Health care providers now have access to free toolkit to improve youth smoking cessation programs

Health care providers and educators nationwide who run youth smoking cessation programs now have access to a free toolkit to improve their programs.

29 Apr 2010

New MDC tool provides alternative choices to user's current prescription drugs

Healthcare reform legislation has enacted changes that will significantly affect the Medicare Part D prescription drug program. The most immediate impact of the reform aims to close the "donut hole", a component of the benefit design in which seniors must pay the full cost for their drugs themselves.

29 Apr 2010

Incorporation of NexACT technology helps reduce dose of Å6 compound for ovarian cancer treatment

NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that results from a pre-clinical study showed significant improvement in the delivery and half life of Å6, a proprietary peptide treatment for ovarian cancer currently in Phase 2 development by Angstrom Pharmaceuticals. Specifically, the incorporation of NexACT® enabled the dose of Å6 to be cut by half, or from twice per day to once per day delivered subcutaneously, while achieving the same level of efficacy in the mouse lung metastasis model.

29 Apr 2010

Cardiac Science responds to FDA communications on AED recall

Cardiac Science Corporation, responded to FDA communications released yesterday related to the AED recall first announced in November, 2009. The Agency communication specifies additional affected models and offers further guidance to users of AEDs affected by potential component defects in some of the Company's AEDs.

29 Apr 2010

miacom diagnostics announces new tests for faster diagnosis of sepsis

"Conventional PCR tests (PCR is short for polymerase chain reaction, a highly sensitive method of detecting nucleic acids) require several hours to produce a result. lucesco Bacteremia IVD panels are not only much faster with a result after only 30 minutes, they are also much more cost-efficient.

29 Apr 2010

Device / Technology News

New tool to detect inflammatory eye disease at molecular level before damage occurs

CT Dose Summit to establish freely available guidelines for performing CT scans

States move to require ultrasounds before abortions

Generex Biotechnology receives U.S. patent for method of administering insulin to the buccal region

CSI announces completion of enrollment in CALCIUM 360° clinical trial for PAD

EndoChoice granted FDA marketing clearance for BONASTENT Esophageal and Biliary Stent platforms

A crystal ball into your future health!

ZOLL Medical's second-quarter revenues up 15% to $107.1 million

IMD seeks FDA regulatory clearance for NADiA ProsVue prostate cancer prognostic test

NeoGenomics first-quarter revenue up 22%

Orion Health Rhapsody Integration Engine to be deployed across Philips' healthcare informatics solutions

China Medical Technologies' AUTOMAGLIA 90 analyzer and Down Syndrome Screening receive SFDA approval

Artificial heart to be a reality soon, expect researchers

New FineThanx phone system gives peace of mind to elderly patients

Tomophase receives seventh U.S. Patent for OCTIS component

Health care providers now have access to free toolkit to improve youth smoking cessation programs

New MDC tool provides alternative choices to user's current prescription drugs

Incorporation of NexACT technology helps reduce dose of Å6 compound for ovarian cancer treatment

Cardiac Science responds to FDA communications on AED recall

miacom diagnostics announces new tests for faster diagnosis of sepsis

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News